Published in J Neurosurg on February 01, 2008
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
Role of subdural electrocorticography in prediction of long-term seizure outcome in epilepsy surgery. Brain (2009) 1.68
Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain (2009) 1.49
Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg (2015) 1.39
Mutant IDH1 and seizures in patients with glioma. Neurology (2017) 1.39
Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol (2012) 1.37
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol (2009) 1.06
Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci (2014) 1.02
Rates and predictors of seizure freedom in resective epilepsy surgery: an update. Neurosurg Rev (2014) 1.02
Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg (2010) 1.02
Morphological characteristics of brain tumors causing seizures. Arch Neurol (2010) 1.01
Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist (2014) 0.98
Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro Oncol (2011) 0.95
Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol (2013) 0.94
Factors associated with failed focal neocortical epilepsy surgery. Neurosurgery (2014) 0.93
Anaplastic oligodendroglioma. Curr Treat Options Neurol (2008) 0.93
Low-grade gliomas. Oncologist (2014) 0.90
GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. Glia (2014) 0.85
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro Oncol (2016) 0.83
Seizures and gliomas - towards a single therapeutic approach. Nat Rev Neurol (2016) 0.83
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev (2015) 0.81
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide. J Neurooncol (2015) 0.80
Significance of miR-196b in tumor-related epilepsy of patients with gliomas. PLoS One (2012) 0.80
Use of language mapping to aid in resection of gliomas in eloquent brain regions. Neurosurg Clin N Am (2012) 0.79
Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis. Int J Clin Exp Pathol (2014) 0.79
Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survival. Int J Clin Exp Med (2014) 0.79
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol (2015) 0.79
Epilepsy associated tumors: Review article. World J Clin Cases (2014) 0.78
Trends and outcomes in the treatment of gliomas based on data during 2001-2004 from the Brain Tumor Registry of Japan. Neurol Med Chir (Tokyo) (2015) 0.78
Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies. Childs Nerv Syst (2015) 0.78
Glioma-related seizures: glutamate is the key. Nat Med (2011) 0.78
Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study. Epilepsy Res (2014) 0.78
Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol (2014) 0.78
Current treatment of low grade gliomas. Memo (2012) 0.77
Tumors generate excitement: the role of glutamate in tumor-related epilepsy. Epilepsy Curr (2012) 0.77
Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey. J Neurooncol (2015) 0.76
Intraoperative high-field magnetic resonance imaging combined with functional neuronavigation in resection of low-grade temporal lobe tumors. World J Surg Oncol (2015) 0.75
Second Surgery in Insular Low-Grade Gliomas. Biomed Res Int (2015) 0.75
Epilepsy and brain tumors. Handb Clin Neurol (2016) 0.75
Peritumoral epilepsy: relating form and function for surgical success. Epilepsy Behav (2014) 0.75
Frequency, clinical correlates, and ratings of behavioral changes in primary brain tumor patients: a preliminary investigation. Front Oncol (2015) 0.75
Palliative care and quality of life in neuro-oncology. F1000Prime Rep (2014) 0.75
Managing common complex symptomatic epilepsies: tumors and trauma: american epilepsy society - 2012 annual course summary. Epilepsy Curr (2013) 0.75
Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study. BMC Neurol (2014) 0.75
Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy. Oncotarget (2016) 0.75
The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas. ScientificWorldJournal (2013) 0.75
Seizures in patients undergoing resection of low-grade gliomas. Epilepsy Curr (2009) 0.75
Is there a response shift in generic health-related quality of life 6 months after glioma surgery? Acta Neurochir (Wien) (2016) 0.75
Glial tumors in brodmann area 6: spread pattern and relationships to motor areas. Radiographics (2015) 0.75
Overall survival in adult patients with low-grade, supratentorial glioma: Ten years' follow up at a single institution. Electron Physician (2015) 0.75
Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery. Neurosurg Rev (2015) 0.75
Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol (2017) 0.75
Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. J Neurooncol (2017) 0.75
Treatment of epileptic seizures in brain tumors: a critical review. Neurosurg Rev (2014) 0.75
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol (2010) 14.79
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54
An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Neural stem cells and the origin of gliomas. N Engl J Med (2005) 5.43
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst (2005) 4.63
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol (2008) 4.39
Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12
Glioma extent of resection and its impact on patient outcome. Neurosurgery (2008) 4.02
Functional outcome after language mapping for glioma resection. N Engl J Med (2008) 4.01
Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol (2002) 3.99
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg (2003) 3.91
Inequality in early childhood: risk and protective factors for early child development. Lancet (2011) 3.48
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol (2004) 3.25
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Patterns of care for adults with newly diagnosed malignant glioma. JAMA (2005) 3.08
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol (2007) 3.07
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol (2008) 2.92
High gamma activity in response to deviant auditory stimuli recorded directly from human cortex. J Neurophysiol (2005) 2.88
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71
Categorical speech representation in human superior temporal gyrus. Nat Neurosci (2010) 2.67
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol (2003) 2.63
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov (2012) 2.61
Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol (2007) 2.56
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res (2010) 2.56
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res (2006) 2.44
Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg (2007) 2.43
Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs (2005) 2.30
Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. J Neurosurg (2003) 2.24
Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro Oncol (2009) 2.23
Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann Neurol (2006) 2.22
Comanagement of surgical patients between neurosurgeons and hospitalists. Arch Intern Med (2010) 2.22
Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg (2010) 2.19
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery (2012) 2.19
Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg (2013) 2.16
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg (2011) 2.14
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol (2009) 2.13
Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery (2014) 2.11
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol (2006) 2.11
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res (2004) 2.10
Spatiotemporal dynamics of word processing in the human brain. Front Neurosci (2007) 2.09
Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg (2005) 2.07
Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke (2003) 2.07
Complications of lumboperitoneal shunts. Neurosurgery (2007) 2.07
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma. Neurosurgery (2015) 2.06
Symptomatic enlarged cervical anterior epidural venous plexus in a patient with Marfan syndrome. AJNR Am J Neuroradiol (2002) 2.05
Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01
Society of Neurological Surgeons boot camp courses: knowledge retention and relevance of hands-on learning after 6 months of postgraduate year 1 training. J Neurosurg (2013) 1.97
Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol (2011) 1.92
Spatiotemporal imaging of cortical activation during verb generation and picture naming. Neuroimage (2009) 1.90
Five-dimensional neuroimaging: localization of the time-frequency dynamics of cortical activity. Neuroimage (2008) 1.88
Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage (2007) 1.88
Early childhood stimulation benefits adult competence and reduces violent behavior. Pediatrics (2011) 1.86
Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery (2004) 1.84
Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project. Epilepsia (2011) 1.83
Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol (2005) 1.78
Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg (2007) 1.77
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol (2002) 1.76
Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc (2005) 1.74
Low-grade gliomas in adults. J Neurosurg (2011) 1.73
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet (2012) 1.73
Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72
Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (2008) 1.69
The effect of psychosocial stimulation on cognition and behaviour at 6 years in a cohort of term, low-birthweight Jamaican children. Dev Med Child Neurol (2010) 1.69
Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery (2009) 1.68
Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell (2011) 1.67
Focal cooling suppresses spontaneous epileptiform activity without changing the cortical motor threshold. Epilepsia (2002) 1.67
The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg (2010) 1.67
Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys (2009) 1.67
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66